Advancing physiological maturation in human induced pluripotent stem cell-derived cardiac muscle by gene editing an inducible adult troponin isoform switch.


Journal

Stem cells (Dayton, Ohio)
ISSN: 1549-4918
Titre abrégé: Stem Cells
Pays: England
ID NLM: 9304532

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 16 01 2020
accepted: 11 05 2020
pubmed: 5 6 2020
medline: 7 7 2021
entrez: 5 6 2020
Statut: ppublish

Résumé

Advancing maturation of stem cell-derived cardiac muscle represents a major barrier to progress in cardiac regenerative medicine. Cardiac muscle maturation involves a myriad of gene, protein, and cell-based transitions, spanning across all aspects of cardiac muscle form and function. We focused here on a key developmentally controlled transition in the cardiac sarcomere, the functional unit of the heart. Using a gene-editing platform, human induced pluripotent stem cell (hiPSCs) were engineered with a drug-inducible expression cassette driving the adult cardiac troponin I (cTnI) regulatory isoform, a transition shown to be a rate-limiting step in advancing sarcomeric maturation of hiPSC cardiac muscle (hiPSC-CM) toward the adult state. Findings show that induction of the adult cTnI isoform resulted in the physiological acquisition of adult-like cardiac contractile function in hiPSC-CMs in vitro. Specifically, cTnI induction accelerated relaxation kinetics at baseline conditions, a result independent of alterations in the kinetics of the intracellular Ca

Identifiants

pubmed: 32497296
doi: 10.1002/stem.3235
pmc: PMC7529900
mid: NIHMS1608958
doi:

Substances chimiques

Protein Isoforms 0
Troponin I 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1254-1266

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL132874
Pays : United States

Informations de copyright

©AlphaMed Press 2020.

Références

J Am Coll Cardiol. 1988 Feb;11(2):438-45
pubmed: 3276755
Circulation. 2017 Aug 15;136(7):680-686
pubmed: 28684531
Eur Heart J. 2016 Jun 14;37(23):1789-98
pubmed: 27055812
Am J Physiol Cell Physiol. 2001 Feb;280(2):C324-32
pubmed: 11208528
Circ Res. 1991 Nov;69(5):1409-14
pubmed: 1934363
Nat Biotechnol. 2009 Sep;27(9):851-7
pubmed: 19680244
Circ Res. 2000 Mar 3;86(4):386-90
pubmed: 10700442
Clin Genet. 2019 Dec;96(6):549-559
pubmed: 31568572
Circ Res. 2007 Aug 17;101(4):377-86
pubmed: 17615373
Circ Res. 2000 Mar 3;86(4):470-7
pubmed: 10700453
Sci Rep. 2016 Nov 11;6:36803
pubmed: 27833092
Circ Res. 2004 Feb 6;94(2):146-58
pubmed: 14764650
Toxicol Sci. 2017 Jul 1;158(1):164-175
pubmed: 28453742
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1848-57
pubmed: 22645348
Stem Cell Res Ther. 2011 Mar 04;2(2):11
pubmed: 21375737
J Biol Chem. 1981 Jan 25;256(2):964-8
pubmed: 7451483
Cold Spring Harb Symp Quant Biol. 2010;75:201-9
pubmed: 21209393
FASEB J. 2009 May;23(5):1529-40
pubmed: 19141534
Nat Med. 2006 Feb;12(2):181-9
pubmed: 16429145
Physiol Rev. 2008 Oct;88(4):1567-651
pubmed: 18923190
Circulation. 2017 May 9;135(19):1848-1850
pubmed: 28483831
Annu Rev Biomed Eng. 2014 Jul 11;16:1-28
pubmed: 24819474
Science. 2009 May 8;324(5928):797-801
pubmed: 19325077
Cell Stem Cell. 2016 Apr 7;18(4):541-53
pubmed: 26971820
PLoS One. 2013 Oct 24;8(10):e78768
pubmed: 24205315
J Mol Cell Cardiol. 2012 Sep;53(3):446-57
pubmed: 22683325
Circ Res. 1992 Jan;70(1):104-15
pubmed: 1309313
J Clin Invest. 1997 Nov 1;100(9):2362-70
pubmed: 9410916
Genomics. 1990 Jul;7(3):346-57
pubmed: 2365354
Biophys J. 2012 Apr 4;102(7):1570-9
pubmed: 22500757
Anat Rec (Hoboken). 2014 Sep;297(9):1663-9
pubmed: 25125179
Nat Protoc. 2013 Jan;8(1):162-75
pubmed: 23257984
Methods Enzymol. 2014;546:215-50
pubmed: 25398343
Arch Toxicol. 2015 Sep;89(9):1401-38
pubmed: 25708889
Stem Cell Reports. 2014 Oct 14;3(4):594-605
pubmed: 25358788
Physiol Genomics. 2010 Jul 7;42(2):287-99
pubmed: 20423961
Nat Med. 2013 Mar;19(3):305-12
pubmed: 23396207
Stem Cell Res Ther. 2013 Dec 24;4(6):150
pubmed: 24476344
JAMA Cardiol. 2019 Feb 1;4(2):95-96
pubmed: 30480702
Physiol Rev. 2000 Apr;80(2):853-924
pubmed: 10747208
Biochemistry. 1991 Jan 22;30(3):707-12
pubmed: 1988058
Adv Exp Med Biol. 2003;538:169-74; discussion 174
pubmed: 15098664
J Vis Exp. 2015 Mar 18;(97):
pubmed: 25867738
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2006-17
pubmed: 21890694
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1829-38
pubmed: 26578113
Cell Stem Cell. 2014 Aug 7;15(2):215-226
pubmed: 24931489

Auteurs

Matthew Wheelwright (M)

Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Jennifer Mikkila (J)

Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Fikru B Bedada (FB)

Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Mohammad A Mandegar (MA)

Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA.

Brian R Thompson (BR)

Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Joseph M Metzger (JM)

Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH